Jazz Pharmaceuticals plc (JAZZ) financial statements (2021 and earlier)

Company profile

Business Address FIFTH FLOOR, WATERLOO EXCHANGE
DUBLIN, 4
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1,058 310386426989
Cash and cash equivalents1,058 310386366989
Short-term investments    60 
Receivables396 264224234210
Inventory, net of allowances, customer advances and progress billings95 53433419
Inventory95 53433419
Prepaid expense62 25232521
Other current assets152 68772919
Other undisclosed current assets1,075 515215  
Total current assets:2,840 1,2349687481,258
Noncurrent Assets
Operating lease, right-of-use asset129 
Property, plant and equipment128 20017010786
Intangible assets, net (including goodwill)3,153 3,6593,9273,9061,843
Goodwill958 928948894657
Intangible assets, net (excluding goodwill)2,195 2,7312,9793,0121,186
Deferred income tax assets255 
Other noncurrent assets26 43161428
Other undisclosed noncurrent assets5 674225146
Total noncurrent assets:3,696 3,9694,1554,0522,102
TOTAL ASSETS:6,536 5,2035,1244,8003,360
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities405 307245220188
Accounts payable27 41242222
Accrued liabilities353 265199193164
Taxes payable25 12252
Deferred revenue3 
Debt246 33413638
Deferred revenue and credits911
Contract with customer, liability5
Total current liabilities:654 345294257227
Noncurrent Liabilities
Long-term debt and lease obligation1,989 1,5631,5401,9941,167
Long-term debt, excluding current maturities1,849 1,5631,5401,9941,167
Operating lease, liability140 
Liabilities, other than long-term debt234 228193672367
Deferred revenue and credits1634
Deferred revenue2 
Contract with customer, liability10
Deferred tax liabilities, net  557294
Deferred income tax liabilities130 
Other liabilities101 21917711369
Other undisclosed noncurrent liabilities  309383  
Total noncurrent liabilities:2,222 2,1012,1172,6651,534
Total liabilities:2,876 2,4462,4112,9231,761
Stockholders' equity
Stockholders' equity attributable to parent, including:3,660 2,7572,7131,8771,599
Common stock0 0000
Additional paid in capital2,634 2,1141,9351,6651,563
Accumulated other comprehensive loss(134) (198)(141)(317)(267)
Retained earnings1,160 841918529303
Other undisclosed stockholders' equity attributable to parent1 11 1
Other undisclosed stockholders' equity    1 
Total stockholders' equity:3,660 2,7572,7131,8771,599
TOTAL LIABILITIES AND EQUITY:6,536 5,2035,1244,8003,360

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues2,364 1,8911,6191,4881,325
Revenue, net1,6011,4771,317
Cost of revenue(149)     
Gross profit:2,215 1,8911,6191,4881,325
Operating expenses(1,837) (1,276)(1,090)(896)(817)
Operating income:378 615529592508
Nonoperating income (expense)(3) (7)(10)31
Foreign currency transaction gain (loss), before tax(3) (7)(10)3 
Other nonoperating income     1
Interest and debt expense(76) (57)(38)  
Other undisclosed loss from continuing operations before equity method investments, income taxes(24) (22)(40)(63)(74)
Income from continuing operations before equity method investments, income taxes:275 529441532436
Loss from equity method investments(3) (2)(1)(0) 
Income from continuing operations before income taxes:272 527440532436
Income tax expense (benefit)(34) (80)48(135)(106)
Net income:239 447488397330
Net income attributable to noncontrolling interest     0
Net income available to common stockholders, diluted:239 447488397330

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net income:239 447488397330
Other comprehensive income (loss)89 (57)176(50)(145)
Comprehensive income:328 390664347184
Comprehensive income, net of tax, attributable to noncontrolling interest     0
Comprehensive income, net of tax, attributable to parent:328 390664347184

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: